Inhibrx Biosciences, Inc. 13D and 13G filings for Inhibrx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-08 6:00 pm Purchase | 2022-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | Inhibrx Inc. INBX | 3,147,235 7.200% | 650,849 (+26.07%) | Filing |
| 2023-03-08 6:00 pm Sale | 2022-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | Inhibrx Inc. INBX | 2,496,386 5.700% | -810,924 (-24.52%) | Filing |
| 2023-03-08 5:59 pm Purchase | 2022-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | Inhibrx Inc. INBX | 3,307,310 7.600% | 995,855 (+43.08%) | Filing |
| 2022-02-11 5:37 pm Sale | 2021-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | Inhibrx Inc. INBX | 2,311,455 5.900% | -1,098,669 (-32.22%) | Filing |
| 2022-02-11 5:37 pm Purchase | 2021-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | Inhibrx Inc. INBX | 3,410,124 8.700% | 683,338 (+25.06%) | Filing |
| 2022-02-11 5:37 pm Sale | 2021-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | Inhibrx Inc. INBX | 2,726,786 7.000% | -462,199 (-14.49%) | Filing |
| 2022-02-11 5:37 pm Purchase | 2021-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | Inhibrx Inc. INBX | 3,188,985 8.200% | 3,188,985 (New Position) | Filing |